---
title: "SenesTech, Inc. (SNES.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SNES.US.md"
symbol: "SNES.US"
name: "SenesTech, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-21T23:17:07.788Z"
locales:
  - [en](https://longbridge.com/en/quote/SNES.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNES.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNES.US.md)
---

# SenesTech, Inc. (SNES.US)

## Company Overview

SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [www.senestech.com](https://www.senestech.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:18.000Z

**Overall: C (0.50)**

**Industry**: Pharmaceuticals

| Metric | Value |
|--------|-------|
| Industry Ranking | 101 / 190 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 15.67% |  |
| Net Profit YoY | -12.70% |  |
| P/B Ratio | 1.22 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 9425681.76 |  |
| Revenue | 2229000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -128.03% | E |
| Profit Margin | -304.22% | E |
| Gross Margin | 68.56% | A |
| Revenue YoY | 15.67% | B |
| Net Profit YoY | -12.70% | D |
| Total Assets YoY | 205.10% | A |
| Net Assets YoY | 166.29% | A |
| Cash Flow Margin | 0.00% | D |
| OCF YoY | 15.67% | B |
| Turnover | 0.30 | D |
| Gearing Ratio | 30.39% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - SenesTech, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "15.67%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.70%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.22",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "9425681.76",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2229000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-128.03%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-304.22%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "68.56%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "15.67%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-12.70%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "205.10%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "166.29%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "0.00%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "15.67%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.30",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "30.39%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.39 | 120/190 | - | - | - |
| PB | 1.22 | 58/190 | 3.44 | 1.33 | 0.95 |
| PS (TTM) | 4.23 | 91/190 | 9.83 | 5.13 | 3.92 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cormedix (CRMD.US) | A | A | B | C | B | A |
| 02 | Eli Lilly (LLY.US) | A | A | B | D | B | B |
| 03 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | B | B |
| 04 | Roche (RHHBY.US) | A | B | B | D | B | B |
| 05 | AstraZeneca (AZN.US) | A | B | C | D | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-15T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.79 |
| Highest Target | 10.00 |
| Lowest Target | 10.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SNES.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SNES.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SNES.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SNES.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**